Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients

BACKGROUND: Commercial availability of serological tests to evaluate immunoglobulins (Ig) targeting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has grown exponentially since the start of the coronavirus disease 2019 (COVID-19) outbreak. Thorough validation of these tests is importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Serre-Miranda, C., Nobrega, C., Roque, S., Canto-Gomes, J., Silva, C.S., Vieira, N., Barreira-Silva, P., Alves-Peixoto, P., Cotter, J., Reis, A., Formigo, M., Sarmento, H., Pires, O., Carvalho, A., Petrovykh, D.Y., Diéguez, L., Sousa, J.C., Sousa, N., Capela, C., Palha, J.A., Cunha, P.G., Correia-Neves, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817432/
https://www.ncbi.nlm.nih.gov/pubmed/33484862
http://dx.doi.org/10.1016/j.ijid.2021.01.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817432/
https://www.ncbi.nlm.nih.gov/pubmed/33484862
http://dx.doi.org/10.1016/j.ijid.2021.01.038

Ejemplares similares